Screening of Coexistence Between Sickle Cell Anaemia and G6PD Deficiency

Launched by FATMA HUSSEIN MAHMOUD · Sep 24, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the relationship between two conditions: Sickle Cell Disease (SCD) and G6PD deficiency. Sickle Cell Disease affects how red blood cells behave, while G6PD deficiency can lead to problems with red blood cell function. Researchers want to understand how having both conditions might affect a patient's health, specifically how it can increase the severity of anemia and lead to more hospital visits and pain crises in patients. This information will help doctors make better treatment choices for those who have both conditions.

The trial is looking for newborns aged 1 to 28 who are generally healthy. However, babies with certain health issues, like a high number of reticulocytes (young red blood cells) or poor overall health, will not be eligible to participate. If your child is eligible and joins the study, they will be monitored to see how these two conditions interact and what that means for their health. This research aims to improve understanding and treatment options for children with Sickle Cell Disease and G6PD deficiency.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - All new born with good general health
• Exclusion Criteria:
• • 1-new born with high reticulocytic count 2-new born with bad general health